NASDAQ:MDXG MiMedx Group (MDXG) Stock Price, News & Analysis $7.76 +0.05 (+0.65%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$7.63▼$7.8550-Day Range$6.67▼$8.0052-Week Range$5.57▼$9.27Volume628,507 shsAverage Volume749,472 shsMarket Capitalization$1.15 billionP/E Ratio17.64Dividend YieldN/APrice Target$12.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get MiMedx Group alerts: Email Address MiMedx Group MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside54.6% Upside$12.00 Price TargetShort InterestBearish3.42% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.47Based on 4 Articles This WeekInsider TradingN/AProj. Earnings Growth53.13%From $0.32 to $0.49 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.76 out of 5 starsMedical Sector247th out of 936 stocksSurgical & Medical Instruments Industry32nd out of 101 stocks 3.5 Analyst's Opinion Consensus RatingMiMedx Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageMiMedx Group has only been the subject of 2 research reports in the past 90 days.Read more about MiMedx Group's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted3.42% of the outstanding shares of MiMedx Group have been sold short.Short Interest Ratio / Days to CoverMiMedx Group has a short interest ratio ("days to cover") of 6.9.Change versus previous monthShort interest in MiMedx Group has recently increased by 2.23%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldMiMedx Group does not currently pay a dividend.Dividend GrowthMiMedx Group does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for MDXG. Previous Next 3.0 News and Social Media Coverage News SentimentMiMedx Group has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for MiMedx Group this week, compared to 2 articles on an average week.Search Interest12 people have searched for MDXG on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.MarketBeat Follows3 people have added MiMedx Group to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, MiMedx Group insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.30% of the stock of MiMedx Group is held by insiders.Percentage Held by Institutions79.15% of the stock of MiMedx Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about MiMedx Group's insider trading history. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for MiMedx Group are expected to grow by 53.13% in the coming year, from $0.32 to $0.49 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of MiMedx Group is 17.64, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 140.44.Price to Earnings Ratio vs. SectorThe P/E ratio of MiMedx Group is 17.64, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 148.37.Price to Book Value per Share RatioMiMedx Group has a P/B Ratio of 7.92. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about MiMedx Group's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyObama wins Presidential debate When I said Obama would seek a third term… They called me a conspiracy theorist, they said it couldn’t happen, that the 22nd Amendment makes it impossible. But as I explained on live radio years ago, “he could have a proxy… while he remains in control of the administration much like Putin did in Russia.” Please, watch this now before it’s too late. About MiMedx Group Stock (NASDAQ:MDXG)MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company's products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was incorporated in 2011 and is headquartered in Marietta, Georgia.Read More MDXG Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MDXG Stock News HeadlinesJuly 26 at 7:51 PM | markets.businessinsider.comCraig-Hallum Gives a Buy Rating to MiMedx Group (MDXG)July 22, 2024 | globenewswire.comMIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature – Scientific ReportsJuly 26, 2024 | Monument Traders Alliance (Ad)NEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands of Americans...July 19, 2024 | finance.yahoo.comMIMEDX to Host Second Quarter 2024 Operating and Financial Results Conference Call on July 31July 1, 2024 | investorplace.com7 Undervalued Biotech Stocks to Buy for Big-Time ReturnsJune 26, 2024 | globenewswire.comMIMEDX Announces the Appointment of Kim Moller to Chief Commercial OfficerMay 27, 2024 | msn.comCompare with MiMedx Group Inc (MDXG)May 15, 2024 | globenewswire.comMIMEDX to Participate in Upcoming Investor ConferencesJuly 26, 2024 | Monument Traders Alliance (Ad)NEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands of Americans...May 2, 2024 | finance.yahoo.comMiMedx Group, Inc. (NASDAQ:MDXG) Q1 2024 Earnings Call TranscriptMay 2, 2024 | markets.businessinsider.comBuy Rating Affirmed for MiMedx on Strong Performance and Favorable Market OutlookMay 1, 2024 | finance.yahoo.comMDXG: MACs Give Credit for EfficacyMay 1, 2024 | markets.businessinsider.comMiMedx Group: Strong Financial Performance and Future Growth Potential Affirm Buy RatingMay 1, 2024 | finance.yahoo.comQ1 2024 MiMedx Group Inc Earnings CallMay 1, 2024 | finanznachrichten.deMiMedx Group, Inc: MIMEDX Announces First Quarter 2024 Operating and Financial ResultsMay 1, 2024 | finance.yahoo.comMiMedx Group Inc (MDXG) Q1 2024 Earnings Call Transcript Highlights: Strong Financial ...April 30, 2024 | markets.businessinsider.comMDXG Stock Earnings: MiMedx Group Beats EPS, Beats Revenue for Q1 2024April 30, 2024 | globenewswire.comMIMEDX Announces First Quarter 2024 Operating and Financial ResultsSee More Headlines Receive MDXG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MiMedx Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/30/2024Today7/26/2024Next Earnings (Confirmed)7/31/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:MDXG CUSIPN/A CIK1376339 Webwww.mimedx.com Phone(770) 651-9100Fax678-384-6741Employees870Year FoundedN/APrice Target and Rating Average Stock Price Target$12.00 High Stock Price Target$14.00 Low Stock Price Target$11.00 Potential Upside/Downside+56.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)$0.44 Trailing P/E Ratio17.45 Forward P/E Ratio24.00 P/E GrowthN/ANet Income$58.23 million Net Margins18.63% Pretax Margin13.13% Return on Equity39.42% Return on Assets13.70% Debt Debt-to-Equity Ratio0.12 Current Ratio3.29 Quick Ratio2.71 Sales & Book Value Annual Sales$321.48 million Price / Sales3.53 Cash Flow$0.20 per share Price / Cash Flow39.25 Book Value$0.98 per share Price / Book7.84Miscellaneous Outstanding Shares147,600,000Free Float145,685,000Market Cap$1.13 billion OptionableOptionable Beta1.99 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Joseph H. Capper (Age 60)CEO & Director Comp: $1.55MMr. Douglas C. Rice CPA (Age 58)Chief Financial Officer Comp: $470.47kMr. William F. Hulse IV (Age 50)General Counsel & Chief Administrative Officer Comp: $959.59kMr. Scott M. Turner (Age 58)Senior Vice President of Operations & Procurement Comp: $493.98kMr. Matthew M. NotarianniHead of Investor RelationsMr. Mark P. Graves (Age 58)Senior VP & Chief Compliance Officer Hilary DixonVice President of Investor Relations & Corporate Strategic CommunicationsMs. Kate SurdezChief Human Resources OfficerDr. David H. Mason Jr. (Age 77)Chief Medical Officer Dr. Robert Benjamin Stein M.D. (Age 73)Ph.D., President of Regenerative Medicine & Biologics Innovation Comp: $639.28kMore ExecutivesKey CompetitorsIntersect ENTNASDAQ:XENTCryoLifeNYSE:CRYVapothermNYSE:VAPOInspire Medical SystemsNYSE:INSPPROCEPT BioRoboticsNASDAQ:PRCTView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpBought 35,107 shares on 7/26/2024Ownership: 0.277%Allspring Global Investments Holdings LLCBought 15,240 shares on 7/26/2024Ownership: 0.123%Parsons Capital Management Inc. RISold 10,000 shares on 7/20/2024Ownership: 0.147%SG Americas Securities LLCSold 40,261 shares on 7/12/2024Ownership: 0.015%Harbor Capital Advisors Inc.Bought 256,994 shares on 7/9/2024Ownership: 0.174%View All Insider TransactionsView All Institutional Transactions MDXG Stock Analysis - Frequently Asked Questions How have MDXG shares performed this year? MiMedx Group's stock was trading at $8.77 at the start of the year. Since then, MDXG shares have decreased by 11.5% and is now trading at $7.76. View the best growth stocks for 2024 here. How were MiMedx Group's earnings last quarter? MiMedx Group, Inc. (NASDAQ:MDXG) posted its quarterly earnings data on Tuesday, April, 30th. The company reported $0.07 EPS for the quarter, topping the consensus estimate of $0.04 by $0.03. The business earned $84.71 million during the quarter, compared to the consensus estimate of $79.36 million. MiMedx Group had a net margin of 18.63% and a trailing twelve-month return on equity of 39.42%. Who are MiMedx Group's major shareholders? Top institutional investors of MiMedx Group include Bank of New York Mellon Corp (0.28%), Harbor Capital Advisors Inc. (0.17%), Parsons Capital Management Inc. RI (0.15%) and Allspring Global Investments Holdings LLC (0.12%). Insiders that own company stock include Timothy R Wright, William Frank Iv Hulse, Rohit Kashyap, Robert Benjamin Stein, Scott M Turner, William Lawrence Phelan and Mark Graves. View institutional ownership trends. How do I buy shares of MiMedx Group? Shares of MDXG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:MDXG) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MiMedx Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MiMedx Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MDXG Stock Alerts